Croatia HZZO boosts expensive drug budget €45M on price hikes, new therapies

Croatia's HZZO will raise spending on special expensive medicines by €45 million to €470 million, citing higher prices, new drug launches, and expanded indications. The increase signals rising fiscal pressure on Croatia's public health system from specialty pharmaceuticals, though the exact mix of drivers is not quantified.